Al Razi Medical Company

Al Razi Medical Company

TTADAWUL:9572
25.30
SAR
-0.66
(-2.54%)
48.49MMarket Cap

Total Valuation

SAR

As of June 30, 2026, Al Razi Medical Company carries a market capitalization of 48.49M, placing it among publicly traded companies globally. Its enterprise value stands at 59.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap48.49M
Enterprise Value59.03M

Share Statistics

As of June 30, 2026, Al Razi Medical Company has 1.52M shares outstanding.

Shares Outstanding1.52M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio2.03
P/TBV Ratio2.04

Financial Position

As of June 30, 2026, Al Razi Medical Company maintains a current ratio of 1.58, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

Current Ratio1.58
Quick Ratio0.02
Debt / Equity45.30

Stock Price Statistics

SAR

As of the close on November 17, 2026, Al Razi Medical Company's stock has declined approximately 24.02% over the past 52 weeks. The 50-day moving average sits at 23.96, while the 200-day moving average is 28.06.

52-Week Price Change-24.02%
50-Day Moving Average23.96
200-Day Moving Average28.06

Balance Sheet

SAR

As of June 30, 2026, Al Razi Medical Company holds 294,231.00 in cash and equivalents against 10.84M in total debt, resulting in a net debt position of 1.43M. Total book value stands at 23.92M, with working capital of 9.41M providing operational flexibility.

Cash & Cash Equivalents294,231.00
Total Debt10.84M
Net Debt1.43M
Equity (Book Value)23.92M
Book Value Per Share15.74
Working Capital9.41M